Founders
Dr. Nadezda Gracheva
Co-founder
Dr. Nadezda Gracheva is a scientist with a background in Radiochemistry and Radiopharmacy as a branch of Nuclear Medicine. She obtained a Ph.D. degree at ETH Zurich, where she was responsible for the development of novel radioactive nuclides for Targeted Radionuclide Therapy to promote innovative cancer treatments.
Dr. Natasa Cmiljanovic
Co-founder
Dr. Natasa Cmiljanovic is a dynamic and accomplished professional, serving as the Chief Operating Officer and Founder of Swiss Rockets. With over a decade of invaluable experience in oncology drug development, Natasa's background as a medicinal chemist and clinical scientist makes her a driving force in the field.
Dr. Vladimir Cmiljanovic
Co-founder
Dr. Vladimir Cmiljanovic is a renowned serial biotech entrepreneur, cancer scientist, and medicinal chemist with over 15 years of experience in oncology drug development.
Prof. Dr. Andreas Türler
Co-founder
Prof. Dr. Andreas Türler is the Chief Radiochemist at Torpedo and publisher of 157 peer reviewed articles. Andreas has been a full professor at the University of Bern and head of the Laboratory of Radiochemistry at the Paul Scherrer Institute (LRC) for 15 years.
Prof. Dr. Med. Richard Baum
Co-founder
Professor Baum is an expert in Nuclear Medicine and Precision Oncology. He is a Professor of Nuclear Medicine at the University of Frankfurt / Main.
Andreas Emmenegger
Co-founder
Andreas has more than 20 years of experience as the CFO of public and private multinational companies, including 15 years in the biotech industry.
Dr. Vladan Vuletić
Co-founder
Professor Vladan Vuletić earned the Physics Diploma with highest honors from the Ludwig-Maximilians-Universität München in 1992, and a Ph.D. in Physics (summa cum laude) from the same institution under the supervision of Professor T.W. Haensch in 1997.